Search research articles
Contact Us
Filters
Showing results (151-160 of 214) with videos related to
Page
of 22
Sort By:
Gastroenterology
|
August 1, 1992
Familial aggregation of inflammatory bowel disease in northern Italy: a multicenter study. The Gruppo di Studio per le Malattie Infiammatorie Intestinali (IBD Study Group)
G Meucci, M Vecchi, G Torgano, et al.
The American Journal of Pathology
|
July 5, 2001
Are syndromic fundic gland polyps true neoplasms?
P Declich, M Porcellati, S Bellone, et al.
The Italian Journal of Gastroenterology
|
September 1, 1991
Action of glucomannans on complaints in patients affected with chronic constipation: a multicentric clinical evaluation
S Passaretti, M Franzoni, U Comin, et al.
Melanoma Research
|
November 1, 1992
Treatment of recurrent in transit metastases from cutaneous melanoma by isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine activated killer cells. A pilot study
F Belli, F Arienti, L Rivoltini, et al.
Plos One
|
March 15, 2014
Responses to elevated c-di-GMP levels in mutualistic and pathogenic plant-interacting bacteria
Daniel Pérez-Mendoza, Isabel M Aragón, Harold A Prada-Ramírez, et al.
Gastrointestinal Endoscopy
|
July 7, 2000
The ASGE guidelines for the appropriate use of colonoscopy in an open access system
G Minoli, G Meucci, A Bortoli, et al.
The American Journal of Gastroenterology
|
January 1, 1994
Biphasic diurnal periodicity in bleeding from peptic ulcer
G Minoli, V Terruzzi, G Imperiali, et al.
Aesthetic Surgery Journal
|
September 27, 2024
Artificial Intelligence Analysis of Periorbital Rejuvenation
Caroline C Kreh, Laura Roider, Peter K Firouzbakht, et al.
The Italian Journal of Gastroenterology
|
September 1, 1995
First bleeding episode from oesophageal varices in cirrhotic patients: a prospective study of endoscopic predictive factors
E Colombo, M A Casiraghi, G Minoli, et al.
Tumori
|
June 30, 1989
A phase II study of the administration of recombinant interleukin 2 (rIL-2) plus lymphokine activated killer (LAK) cells in stage IV melanoma patients
N Cascinelli, F Belli, S Marchini, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 214) with videos related to
Sort By:
Page
of 22
Gastroenterology
|
August 1, 1992
Familial aggregation of inflammatory bowel disease in northern Italy: a multicenter study. The Gruppo di Studio per le Malattie Infiammatorie Intestinali (IBD Study Group)
G Meucci, M Vecchi, G Torgano, et al.
The American Journal of Pathology
|
July 5, 2001
Are syndromic fundic gland polyps true neoplasms?
P Declich, M Porcellati, S Bellone, et al.
The Italian Journal of Gastroenterology
|
September 1, 1991
Action of glucomannans on complaints in patients affected with chronic constipation: a multicentric clinical evaluation
S Passaretti, M Franzoni, U Comin, et al.
Melanoma Research
|
November 1, 1992
Treatment of recurrent in transit metastases from cutaneous melanoma by isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine activated killer cells. A pilot study
F Belli, F Arienti, L Rivoltini, et al.
Plos One
|
March 15, 2014
Responses to elevated c-di-GMP levels in mutualistic and pathogenic plant-interacting bacteria
Daniel Pérez-Mendoza, Isabel M Aragón, Harold A Prada-Ramírez, et al.
Gastrointestinal Endoscopy
|
July 7, 2000
The ASGE guidelines for the appropriate use of colonoscopy in an open access system
G Minoli, G Meucci, A Bortoli, et al.
The American Journal of Gastroenterology
|
January 1, 1994
Biphasic diurnal periodicity in bleeding from peptic ulcer
G Minoli, V Terruzzi, G Imperiali, et al.
Aesthetic Surgery Journal
|
September 27, 2024
Artificial Intelligence Analysis of Periorbital Rejuvenation
Caroline C Kreh, Laura Roider, Peter K Firouzbakht, et al.
The Italian Journal of Gastroenterology
|
September 1, 1995
First bleeding episode from oesophageal varices in cirrhotic patients: a prospective study of endoscopic predictive factors
E Colombo, M A Casiraghi, G Minoli, et al.
Tumori
|
June 30, 1989
A phase II study of the administration of recombinant interleukin 2 (rIL-2) plus lymphokine activated killer (LAK) cells in stage IV melanoma patients
N Cascinelli, F Belli, S Marchini, et al.
Page
of 22